BMJ 2006;333:733-737 (7 October), doi:10.1136/bmj.38975.390370.7C
Clinical review
How to measure renal function in clinical practice
Jamie Traynor, specialist registrar1,
Robert Mactier, consultant nephrologist2,
Colin C Geddes, consultant nephrologist1,
Jonathan G Fox, consultant nephrologist2
1 Renal Unit, Western Infirmary, Glasgow G11 6NT,
2 Renal Unit, Glasgow Royal Infirmary
Correspondence to: J Traynor jamie.traynor{at}northglasgow.scot.nhs.uk
Introduction
The reliable measurement of renal excretory function is of great
importance in clinical practice and in research. The introduction
of routine reporting of estimated glomerular filtration rate
and a new definition of chronic kidney disease has renewed interest
in methods of measuring renal function. Coupled with this is
the fact that several countries are moving towards population
screening for renal impairment to try to reduce the associated
increased cardiovascular risk. Accurate measurement is methodologically
difficult so surrogate measures such as serum creatinine levels
and prediction formulas (based on factors such as the patient's
age, sex, and serum creatinine level) are more commonly used
in routine practice. We describe routine and more specialised
methods of assessing renal function and discuss estimated glomerular
filtration rate.
The kidney has several interlinked functions (box). These depend on glomerular filtration rate, the unit measure of kidney function. Glomerular filtration rate can be defined as the volume of plasma cleared of an ideal substance per unit of time (usually expressed as ml/min). The ideal substance is one that is freely filtered at the glomerulus and neither secreted nor reabsorbed by the renal tubules.
Creatinine
Creatinine is the closest to an ideal endogenous substance for
measuring glomerular filtration rate.
w1 Plasma creatinine is
almost exclusively a product of the metabolism of creatine and
phosphocreatine in skeletal muscle, although ingestion of meat
may also contribute slightly.
w2 w3 In patients with stable renal
function, serum creatinine levels are usually constant, with
variability daily of about only 8%.
w4 w5 Creatinine is freely
filtered at the glomerulus and is not reabsorbed, but up to
15% is actively secreted by the tubules.
w6 In advanced renal
failure, excretion of creatinine through the gastrointestinal
tract increases.
w7
Creatinine clearance
Measuring the creatinine clearance using serum creatinine level
and a timed urine collection gives an estimate of glomerular
filtration rate:
As a result of tubular secretion of creatinine, creatinine clearance tends to overestimate true glomerular filtration rate. This is a systematic error of fairly stable magnitude, however, until advanced renal failure is reached, allowing creatinine clearance to be a reasonable method of following changes of renal function in patients. The main problem with creatinine clearance is the requirement for urine collection over 24 hours; patients find this inconvenient and therefore collections are often inaccurate. Also a 25% daily variation in the values obtained using this method has been reported.w8 Creatinine clearance is therefore no longer much used in clinical practice.
| Summary points
Estimated glomerular filtration rate forms the basis for the classification of chronic kidney disease
An estimated glomerular filtration rate of 60-89 ml/min/1.73 m2 in the absence of other evidence of kidney disease does not signify chronic kidney disease and does not indicate that further testing is required
Patients with chronic kidney disease are at high risk of cardiovascular disease
Estimated glomerular filtration rates, calculated using the "4-v MDRD" based formula, are now routinely reported by biochemistry laboratories alongside serum creatinine results (except in non-validated patient groups)
Serum creatinine levels or estimated glomerular filtration rates may be used to monitor changes in renal function in an individual patient
Formal measurement of glomerular filtration rate is used for accurate assessment of renal function in potential kidney donors and in research studies
Radioisotope or iothalamate methods require multiple blood samples and, if renal function is reduced, the duration of sampling may be up to 24 hours
| |
| Sources and selection criteria
We searched Medline from 1966 onwards using the search terms: "measurement of renal function", "modification of diet in renal disease", "Cockcroft and Gault", "radio-isotopes", "glomerular filtration rate", "inulin clearance", and "cystatin C"
We also referred to several textbooks, including the Oxford Textbook of Clinical Nephrology third edition (Oxford University Press) and Comprehensive Clinical Nephrology second edition (Mosby)
| |
Urea
Serum urea is a less reliable marker of glomerular filtration
rate than creatinine because levels are more vulnerable to change
for reasons unconnected to glomerular filtration rate. A high
protein diet, tissue breakdown, major gastrointestinal haemorrhage,
and corticosteroid therapy can lead to an increase in plasma
urea whereas a low protein diet and liver disease can lead to
a reduction. Also, 40-50% of filtered urea may be reabsorbed
by the tubules, although the proportion is reduced in advanced
renal failure.
w9

View larger version (24K):
[in this window]
[in a new window]
[PowerPoint Slide for Teaching]
|
Fig 1 Biphasic disappearance of injected substance from plasma. During the first phase, equilibration of the injected substance takes place between the intravascular and extravascular compartments (k2). Once equilibration has been reached, the decline in plasma levels (normally measured with a venous sample) should reflect removal of the substance from the arterial system through the kidneys. This is termed the terminal elimination phase (k1)
|
|
Mean of urea and creatinine clearance
In advanced renal failure the mean of urea and creatinine clearance
may give a more accurate estimate of glomerular filtration rate
than either clearance alone, as the effects of urea reabsorption
and creatinine secretion tend to cancel each other out.
w10 It
is the recommended method for estimating residual renal function
w11 in patients receiving dialysis.
Inulin clearance
No endogenous ideal substance exists for measuring glomerular
filtration rate, so the standard method requires infusion of
an exogenous agent, such as inulin. Inulin, a polymer of fructose
(5200 daltons), is found in Jerusalem artichokes, dahlias, and
chicory and was first used for measuring glomerular filtration
rate in 1951.
w12 Its use is limited because purified inulin
is expensive and difficult to measure and measuring glomerular
filtration rate in this way is time consuming for both patients
and clinicians. A bolus and infusion of inulin are given to
achieve a steady plasma level, followed by collection of regular
blood and urine samples over several hours for inulin estimation.
This method (nowadays often using polyfructosan (Inutest; Fresenius,
Austria) is only used in research studies when very accurate
estimation of renal function is necessary.
| Functions of kidney related to glomerular filtration rate
- Excretion of:
Nitrogenous waste
Sodium
Free water
Potassium
Phosphate
Water soluble medicines (for example, digoxin, gentamicin)
- Control of blood pressure
- Acid-base balance
- Secretion of erythropoietin
- Hydroxylation of vitamin D1 (activation)
- Gluconeogenesis in the fasting state
- Catabolism of peptide hormones (including insulin)
| |
Radioisotopic methods
From the late 1960s the use of radionuclides has offered an
alternative method of estimating glomerular filtration rate
that avoids some of the practical disadvantages of inulin clearance.
Estimates using radionuclides correlate closely with inulin
clearance.
1-4 Radionuclides are usually given as a single dose
and the glomerular filtration rate calculated by their rate
of disappearance from the plasma, obviating the need for urine
tests. When a substance is given under these conditions, two
phases of disappearance occur (
fig 1):
Computer software is used to calculate the glomerular filtration rate based on data either from both phases (double pool) or from the terminal elimination phase (single pool). Single pool methods have the advantage that fewer plasma samples are required.
Radioisotopic methods have the disadvantage of precautions being required in handling and disposal of radioactive materials. They are also expensive and not suitable for use during pregnancy. Another important consideration is that the terminal elimination phase is significantly prolonged in advanced renal failure. In patients with moderate renal failure (glomerular filtration rate 30-59 ml/min) samples are taken for up to five hours after injection whereas in patients with advanced renal failure samples are required for up to 24 hours after injection.5
Radiocontrast agents
Radiocontrast agents were initially available in the 1960s but
difficulties in chemical analysis and unacceptable amounts of
free iodine in the preparations limited their use in favour
of radioisotopic agents.
w13 These problems have largely been
resolved and radiocontrast agents now offer the advantages of
radioisotopes without the concerns of radioactive substances.
Agents currently in use are iothalamate (Conray; Mallinckrodt,
St Louis, MO), siatrizoate meglumine (Hypaque; Amersham Health,
NJ), and iohexol (Omnipaque; Amersham Health, NJ). Iohexol may
be the agent of choice as it is relatively quick to use and
its results are comparable to inulin clearance.
6 7
Cystatin C
The past decade has witnessed an upsurge of interest in cystatin
C as an endogenous glomerular filtration rate marker. Cystatin
C is part of the cystatin "superfamily" of cysteine protease
inhibitors. It is freely filtered at the glomerulus. Its use
is, however, limited by higher variability of serum levels than
creatinine (75%
v 7%) between patients.
8 Also, serum levels
are increased in malignancy,
w14 w15 HIV infection,
w16 and glucocorticoid
therapy.
w17 At present cystatin C has no established role, but
it may emerge as a useful way of identifying patients with early
renal failure as part of screening programmes.
w18
Prediction formulas
To circumvent the practical difficulties of formal measurement
of clearance, several prediction formulas have been published.
The most commonly used are the Cockcroft and Gault equation
and formulas based on the modification of diet in renal disease
study (
fig 2). Given the limitations of serum creatinine in
identifying renal failure, the increased use of prediction formulas,
in particular the modification of diet in renal disease formulas,
has been advocated.
9
Cockcroft and Gault equation
The Cockcroft and Gault equation, which estimates creatinine
clearance on the basis of serum creatinine level, age, sex,
and weight, was one of the earliest prediction formulas
10 and
is still widely used. It was based on creatinine excretion in
men with normal renal function with a correction for women,
based on three other studies
w19-w21: it tends to overestimate
renal function at lower levels, particularly when obesity or
fluid overload is present, as the resultant increase in weight
does not reflect an increase in muscle mass. However, as with
creatinine clearance, this is largely a systematic error and
the equation remains useful for following changes in renal function
in a patient.
Modification of diet in renal disease formula
More recently Levey et al introduced a formula derived from
data on patients with advanced renal failure in the modification
of diet in renal disease study.
11-14 This is referred to as
the "6-variable MDRD" or "6-v MDRD" formula.
15 This formula
gives an estimate of glomerular filtration rate in millilitres
per minute adjusted for body surface area of 1.73 m
2 and is
based on a patient's age, sex, race, and levels of serum urea,
serum creatinine, and serum albumin. By avoiding inclusion of
weight, the formula is less prone to errors from fluid overload
and obesity.
In 2000 a simplification of the modification of diet in renal disease formula using only patient's age, sex, race, and serum creatinine level was derived from the original data.16 This is referred to as the "4-variable MDRD" or "4-v MDRD" formula. With the exception of race, the other variables required are normally provided routinely when a sample is submitted to the laboratory. It is therefore much easier for laboratories to report estimated glomerular filtration rate using this formula.
One important issue concerning the use of prediction formulas is that different laboratories use different methods for creatinine estimation. Some assays are more sensitive than others to non-creatinine chromogens, which falsely increase creatinine values. This error is magnified in prediction formulas, particularly in patients with higher levels of renal function.17 18 To replicate as closely as possible the results obtained in the modification of diet in renal disease study, all serum creatinine values should ideally be determined using the methods of the Cleveland Clinic laboratory in the original modification of diet in renal disease study.17 18 This raises problems for different providers of analytical systems and would not be straightforward to achieve. However, some of the difference in assay methods can be corrected for and there are plans to adopt correction factors throughout the United Kingdom. The United Kingdom National External Quality Assessment Service has played a key part in this change. When using a correction factor, the formula used is a slightly modified form of the 4-v MDRD formula.19
The modification of diet in renal disease formulas have been validated in an ever increasing number of patient groups, including elderly patients and recipients of renal transplants,20-22 although concern has been expressed over reliability in different ethnic groups such as Chinese and Indian patients.23 24 Also, as these formulas were based on data from patients with advanced renal failure, their validity has been questioned in patients with normal or near normal glomerular filtration rates. It is therefore recommended that they are not used routinely at levels greater than 60 ml/min/1.73 m2. It should be stressed that these formulas are not valid in certain clinical settings such as acute renal failure, pregnancy, severe malnutrition, diseases of skeletal muscle, paraplegia, and quadriplegia, in children, or when renal function is changing rapidly.
Plans are in progress to report estimated glomerular filtration rates whenever measurement of serum creatinine is requested throughout the United Kingdom. Some centres have already started providing estimated glomerular filtration rates routinely and most centres should be doing so by the end of 2006. This is likely to identify large numbers of patients with reduced glomerular filtration rates who may have been overlooked when their renal function was assessed by serum creatinine levels alone: data from the United States suggest that around 5% of adults have chronic kidney disease stages 3 (glomerular filtration rate 30-59 ml/min), 4 (15-29 ml/min), or 5 (< 15 ml/min). These people have a markedly increased risk of cardiovascular morbidity and mortality and identification of them should enable earlier initiation of measures to reduce cardiovascular risk and also the rate of progression of renal failure. A similar prevalence figure has been reported in the United Kingdom.25 The table lists the five stages of chronic kidney disease.
The UK Renal Association among associations in other countries, including Canada and Australia, has introduced guidelines for targeted screening to detect reduced renal function in primary care using estimated glomerular filtration rate. These guidelines describe how to manage most patients in primary care and advise which patients should be referred to nephrologists. In the case of Australia and New Zealand, specific attention is recommended to high risk subgroups such as those of aboriginal descent. The potential impact of identifying patients with reduced renal function has been recognised by the United Kingdom's health service and is reflected in the General Medical Services contract for general practitioners, which now provides remuneration for the identification and monitoring of chronic kidney disease.
| Additional educational resources
Renal Association (www.renal.org/eGFR/)this website has clear information on definition of chronic kidney disease and provides guidelines on management. A section is included for patients
NHS Employers (www.nhsemployers.org/primary)this website provides further details of the general practitioner contract and remuneration of general practitioners within the United Kingdom
National Kidney Foundation (www.kidney.org/kidneyDisease/)this website provides useful information for patients as well as another good resource for health professionals
| |
| Tips for non-specialists
Use estimated glomerular filtration rate as a guide to renal function in conjunction with advice on renal disease from the Renal Association's website (www.renal.org/eGFR/)
If the estimated glomerular filtration rate is < 60 ml/min then:
- Review previous results or repeat the measurement to assess if renal function is stable or declining
- Measure blood pressure and test urine for protein and blood
- Review drugs for potentially nephrotoxic agents, such as angiotensin converting enzyme inhibitors or angiotensin receptor blockers, diuretics, non-steroidal anti-inflammatory drugs, and antibiotics
- Check for urinary symptoms, signs of fluid retention or hypovolaemia, and palpable bladder
- Enter into a chronic disease management programme and decide whether referral to a renal clinic is appropriate, using local guidelines or those from the Renal Association
| |
Conclusion
Prediction formulas using serum creatinine levels are by far
the most widely used methods of measuring renal excretory function
in routine clinical practice. One of these, the modified 4-v
MDRD estimated glomerular filtration rate formula
19 is now being
used for direct reporting of estimated glomerular filtration
rates by laboratories and has become the standard method used
to identify and monitor patients with reduced renal function
in the United Kingdom and elsewhere. It is anticipated that
recognition and appropriate management of patients with chronic
kidney disease will reduce cardiovascular events and slow further
deterioration in renal function in these patients.
References w1-w21 are on bmj.com
Contributors: JT wrote the main draft of the manuscript and oversaw submission. He is guarantor. RM, CCG, and JGF assisted with writing and amending the manuscript.
Competing interests: None declared.
References
- Chantler C, Garnett ES, Parsons V, Veall N. Glomerular filtration rate measurement in man by the single injection methods using 51Cr-EDTA. Clin Sci 1969;37: 169-80.[ISI][Medline]
- Rehling M, Moller ML, Thamdrup B, Lund JO, Trap-Jensen J. Simultaneous measurement of renal clearance and plasma clearance of 99mTc-labelled diethylenetriaminepenta-acetate, 51Cr-labelled ethylenediaminetetra-acetate and inulin in man. Clin Sci (Lond) 1984;66: 613-9.[Medline]
- Israelit AH, Long DL, White MG, Hull AR. Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125Iiothalamate. Kidney Int 1973;4: 346-9.[ISI][Medline]
- Dondi M, Fanti S. Determination of individual renal function through noninvasive methodologies. Curr Opin Nephrol Hypertens 1995;4: 520-4.[Medline]
- Brochner-Mortensen J. Current status on assessment and measurement of glomerular filtration rate. Clin Physiol 1985;5: 1-17.[Medline]
- Gaspari F, Perico N, Matalone M, Signorini O, Azzollini N, Mister M, et al. Precision of plasma clearance of iohexol for estimation of GFR in patients with renal disease. J Am Soc Nephrol 1998;9: 310-3.[Abstract]
- Gaspari F, Perico N, Ruggenenti P, Mosconi L, Amuchastegui CS, Guerini E, et al. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 1995;6: 257-63.[Abstract]
- Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: implications for the assessment of glomerular filtration rate. Clin Chem 1998;44: 1535-9.[Abstract/Free Full Text]
- Lamb EJ, Tomson CR, Roderick PJ, Clinical Sciences Reviews Committee of the Association for Clinical Biochemistry. Estimating kidney function in adults using formulae. Ann Clin Biochem 2005;42: 321-45.[CrossRef][ISI][Medline]
- Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16: 31-41.[ISI][Medline]
- Effects of dietary protein restriction on the progression of moderate renal disease in the modification of diet in renal disease study. JAmSoc Nephrol 1996;7: 2616-26.[Abstract]
- Levey AS, Adler S, Caggiula AW, England BK, Greene T, Hunsicker LG, et al. Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study. Am J Kidney Dis 1996;27: 652-63.[ISI][Medline]
- Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, et al. Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study. Ann Intern Med 1995;123: 754-62.[Abstract/Free Full Text]
- Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med 1994;330: 877-84.[Abstract/Free Full Text]
- Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130: 461-70.[Abstract/Free Full Text]
- Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000;11: A0828.
- Coresh J, Astor BC, McQuillan G, Kusek J, Greene T, Van Lente F, et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002;39: 920-9.[CrossRef][ISI][Medline]
- Van Biesen W, Vanholder R, Veys N, Verbeke F, Delanghe J, De Bacquer D, et al. The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes. Nephrol Dial Transplant 2006;21: 77-83.[Abstract/Free Full Text]
- Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek J, et al. Expressing the MDRD study equation for estimating GFR with IDMS traceable (gold standard) serum creatinine values. J Am Soc Nephrol 2005;16: 69A.[CrossRef]
- Verhave JC, Fesler P, Ribstein J, Du CG, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: influence of age and body mass index. Am J Kidney Dis 2005;46: 233-41.[CrossRef][ISI][Medline]
- Poge U, Gerhardt T, Palmedo H, Klehr HU, Sauerbruch T, Woitas RP. MDRD equations for estimation of GFR in renal transplant recipients. Am J Transplant 2005;5: 1306-11.[CrossRef][ISI][Medline]
- Pierrat A, Gravier E, Saunders C, Caira MV, Ait-Djafer Z, Legras B, et al. Predicting GFR in children and adults: a comparison of the Cockcroft-Gault, Schwartz, and modification of diet in renal disease formulas. [See comment.] Kidney Int 2003;64: 1425-36.[CrossRef][ISI][Medline]
- Zuo L, Ma YC, Zhou YH, Wang M, Xu GB, Wang HY. Application of GFR-estimating equations in Chinese patients with chronic kidney disease. [See comment.] Am J Kidney Dis 2005;45: 463-72.[CrossRef][ISI][Medline]
- Mahajan S, Mukhiya GK, Singh R, Tiwari SC, Kalra V, Bhowmik DM, et al. Assessing glomerular filtration rate in healthy Indian adults: a comparison of various prediction equations. J Nephrol 2005;18: 257-61.[ISI][Medline]
- Anandarajah S, Tai T, De Lusignan S, Stevens P, O'Donoghue D, Walker M, et al. The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): a manual review of 500 medical records. Nephrol Dial Transplant 2005;20: 2089-96.[Abstract/Free Full Text]
(Accepted 29 August 2006)

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Relevant Articles
-
Formula estimation of glomerular filtration rate: have we gone wrong?
- Paul D Giles and David A Fitzmaurice
BMJ 2007 334: 1198-1200.
[Extract]
[Full Text]
[PDF]
-
How to measure renal function in clinical practice: Eating cooked meat alters serum creatinine concentration and eGFR significantly
- David J Preiss, Ian M Godber, and Ian R Gunn
BMJ 2006 333: 1072.
[Extract]
[Full Text]
[PDF]
-
How to measure renal function in clinical practice: Age affects estimated glomerular filtration rate
- Sunil Bhandari
BMJ 2006 333: 918.
[Extract]
[Full Text]
-
How to measure renal function in clinical practice: Estimated glomerular filtration rate in general practice
- Jo Richardson
BMJ 2006 333: 918.
[Extract]
[Full Text]
This article has been cited by other articles:
-
Almond, A., Siddiqui, S., Robertson, S., Norrie, J., Isles, C.
(2008). Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low. QJM
101: 619-624
[Abstract]
[Full text]
-
Geddes, C C, Baxter, G M
(2008). Renal impairment. Imaging
20: 1-19
[Abstract]
[Full text]
-
Quinn, M. P., Rainey, A., Cairns, K. J., Marshall, A. H., Savage, G., Kee, F., Peter Maxwell, A., Reaney, E., Fogarty, D. G.
(2008). The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease. Nephrol Dial Transplant
23: 542-548
[Abstract]
[Full text]
-
Glynn, L. G., Reddan, D., Newell, J., Hinde, J., Buckley, B., Murphy, A. W.
(2007). Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: a West of Ireland community-based cohort study. Nephrol Dial Transplant
22: 2586-2594
[Abstract]
[Full text]
-
Giles, P. D, Fitzmaurice, D. A
(2007). Formula estimation of glomerular filtration rate: have we gone wrong?. BMJ
334: 1198-1200
[Full text]
-
Preiss, D. J, Godber, I. M, Gunn, I. R
(2006). How to measure renal function in clinical practice: Eating cooked meat alters serum creatinine concentration and eGFR significantly. BMJ
333: 1072-1072
[Full text]
-
Bhandari, S.
(2006). How to measure renal function in clinical practice: age affects estimated glomerular filtration rate.. BMJ
333: 918-918
[Full text]
-
Richardson, J.
(2006). How to measure renal function in clinical practice: estimated glomerular filtration rate in general practice.. BMJ
333: 918-918
[Full text]
Rapid Responses:
Read all Rapid Responses
- Renal Function and Age a brief comment
- Sunil Bhandari
bmj.com, 10 Oct 2006
[Full text]
- Urea and creatinine: simple, cheap and have many uses
- Amit Patel
bmj.com, 11 Oct 2006
[Full text]
- Measures of Renal Function
- Andy Bow, et al.
bmj.com, 11 Oct 2006
[Full text]
- eGFR in general practice
- Jo Richardson
bmj.com, 16 Oct 2006
[Full text]
- Estimating renal function using the MDRD-equation – all that simple?
- Michiel F Schreuder, et al.
bmj.com, 17 Oct 2006
[Full text]
- The measurement of renal function in clinical practice
- David G Beevers
bmj.com, 24 Oct 2006
[Full text]
- Do not stop ACEI/ ARAs unless clear contraindications present
- Ramaswamy Diwakar, et al.
bmj.com, 21 Oct 2006
[Full text]
- Time to also change serum creatinine reference value reporting?
- Uptal D Patel
bmj.com, 25 Oct 2006
[Full text]
- Cystatin C level: potential new gold-standard for renal function in critically ill patients?
- Annick A.N.M. Royakkers, et al.
bmj.com, 26 Oct 2006
[Full text]
- Eating cooked meat alters serum creatinine concentration and eGFR significantly
- David J Preiss, et al.
bmj.com, 8 Nov 2006
[Full text]
- Re: Eating cooked meat alters serum creatinine concentration and eGFR significantly
- JK Anand
bmj.com, 8 Nov 2006
[Full text]
- Re: Re: Eating cooked meat alters serum creatinine concentration and eGFR significantly
- David J Preiss, et al.
bmj.com, 9 Nov 2006
[Full text]
- The MDRD-formula in pregnancy
- Friso MC Delemarre, et al.
bmj.com, 5 Dec 2006
[Full text]